Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
      Neisseria gonorrhoeae*/drug effects ; Neisseria gonorrhoeae*/isolation & purification ; Gonorrhea*/epidemiology ; Gonorrhea*/microbiology ; Gonorrhea*/drug therapy ; Gonorrhea*/diagnosis ; Data Accuracy*; Thailand/epidemiology ; Humans ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests/standards ; Databases, Factual ; Population Surveillance/methods ; Drug Resistance, Bacterial
    • نبذة مختصرة :
      Background: Quality assessments of gonococcal surveillance data are critical to improve data validity and to enhance the value of surveillance findings. Detecting data errors by systematic audits identifies areas for quality improvement. We designed and implemented an internal audit process to evaluate the accuracy and completeness of surveillance data for the Thailand Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).
      Methods: We conducted a data quality audit of source records by comparison with the data stored in the EGASP database for five audit cycles from 2015-2021. Ten percent of culture-confirmed cases of Neisseria gonorrhoeae were randomly sampled along with any cases identified with elevated antimicrobial susceptibility testing results and cases with repeat infections. Incorrect and incomplete data were investigated, and corrective action and preventive actions (CAPA) were implemented. Accuracy was defined as the percentage of identical data in both the source records and the database. Completeness was defined as the percentage of non-missing data from either the source document or the database. Statistical analyses were performed using the t-test and the Fisher's exact test.
      Results: We sampled and reviewed 70, 162, 85, 68, and 46 EGASP records during the five audit cycles. Overall accuracy and completeness in the five audit cycles ranged from 93.6% to 99.4% and 95.0% to 99.9%, respectively. Overall, completeness was significantly higher than accuracy (p = 0.017). For each laboratory and clinical data element, concordance was >85% in all audit cycles except for two laboratory data elements in two audit cycles. These elements significantly improved following identification and CAPA implementation.
      Discussion: We found a high level of data accuracy and completeness in the five audit cycles. The implementation of the audit process identified areas for improvement. Systematic quality assessments of laboratory and clinical data ensure high quality EGASP surveillance data to monitor for antimicrobial resistant Neisseria gonorrhoeae in Thailand.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
    • References:
      Emerg Infect Dis. 2011 Jan;17(1):148-9. (PMID: 21192886)
      PLoS Med. 2017 Jul 7;14(7):e1002344. (PMID: 28686231)
      Int J Environ Res Public Health. 2014 May 14;11(5):5170-207. (PMID: 24830450)
      Ethiop J Health Sci. 2012 Nov;22(3):205-8. (PMID: 23209355)
      J Am Geriatr Soc. 2009 Apr;57(4):722-9. (PMID: 19220562)
      Ann Fam Med. 2005 May-Jun;3 Suppl 1:S21-9. (PMID: 15928215)
      Sex Transm Infect. 2013 Dec;89 Suppl 4:iv57-9. (PMID: 24202206)
      Euro Surveill. 2023 Mar;28(10):. (PMID: 36892469)
      Future Microbiol. 2012 Dec;7(12):1401-22. (PMID: 23231489)
      Sex Transm Infect. 2012 Aug;88(5):317-8. (PMID: 22798629)
      Perspect Clin Res. 2011 Apr;2(2):59-63. (PMID: 21731856)
      J Antimicrob Chemother. 2009 Jun;63(6):1142-51. (PMID: 19318360)
      Ann Lab Med. 2017 Sep;37(5):365-370. (PMID: 28643484)
      PLoS Negl Trop Dis. 2016 Nov 3;10(11):e0005053. (PMID: 27812100)
      Euro Surveill. 2014 Nov 13;19(45):20955. (PMID: 25411689)
      PLoS One. 2018 Nov 9;13(11):e0206419. (PMID: 30412586)
      Euro Surveill. 2022 Jun;27(24):. (PMID: 35713023)
      J Am Med Inform Assoc. 2008 May-Jun;15(3):386-9. (PMID: 18308994)
      BMJ Open. 2017 Jul 10;7(7):e015506. (PMID: 28698328)
      MMWR Suppl. 1988 May 6;37(5):1-18. (PMID: 3131659)
      Int J Health Care Qual Assur. 2018 Apr 16;31(3):203-213. (PMID: 29687760)
      Sex Health. 2019 Sep;16(5):412-425. (PMID: 31437420)
      NI 2012 (2012). 2012 Jun 23;2012:301. (PMID: 24199107)
      J Adv Nurs. 2009 Mar;65(3):464-76. (PMID: 19222644)
      Epidemiol Bull. 1995 Mar;16(1):1-6. (PMID: 7794696)
      J Crit Care. 2022 Oct;71:154094. (PMID: 35724443)
      J Manag Care Pharm. 2012 Jan-Feb;18(1):46-53. (PMID: 22235954)
      Milbank Q. 2014 Mar;92(1):7-33. (PMID: 24597553)
      J Biomed Inform. 2018 Jul;83:25-32. (PMID: 29783038)
      Int J Urol. 2012 Feb;19(2):98-9. (PMID: 22168311)
    • الرقم المعرف:
      0 (Anti-Bacterial Agents)
    • الموضوع:
      Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240707
    • الموضوع:
      20240707
    • الرقم المعرف:
      PMC11226028
    • الرقم المعرف:
      10.1371/journal.pone.0305296
    • الرقم المعرف:
      38968209